This video is featured in the 2024 ESMO Annual Meeting Insights Hub

ESMO 2024 Insights: Avelumab-Cetuximab-RT vs. SoC in Locally Advanced HNSCC - Final Analysis From the REACH Trial

109 views
September 20, 2024
0 Comments
Login to view comments. Click here to Login